Project Grant R21AI193181
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$486K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Arizona, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $175,000 to the La Jolla Institute for Immunology to conduct research on the role of Alternaria fungal sensitization in asthma pathogenesis. The research aims to explore the mechanisms and cell types that drive Alternaria sensitization and the development of asthma. Key activities include: Determining the association...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $2,888,757 to the University of Arizona to conduct research on a novel therapeutic approach for asthma treatment. The central focus is investigating the roles of protease-activated receptor-2 (PAR2) signaling in airway epithelial cells and sensory neurons, and evaluating the potential of small molecule PAR2 antagonists...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $424,223 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Florida. The grant, awarded on June 10, 2025, will support research to investigate lipid-gene molecular profiles in septic acute respiratory distress syndrome (ARDS) patients. The key goals are to: 1) identify novel septic ARDS phenotypes based on lipidomic and transcriptomic profiles, and 2) discover...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $730,392 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado-Denver. The 5-year grant, awarded on Jun 17, 2025, supports research to investigate the role of adipose tissue and adipose eosinophils in regulating airway function and inflammation in lean and obese mouse models of asthma. The key objectives are to: 1) Determine the metabolic response of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $260,445 to Brigham & Women's Hospital, Inc. to conduct research on biomarkers predicting nasal polyp recurrence in patients with aspirin-exacerbated respiratory disease (AERD). The research aims to 1) establish a biomarker-based predictive model for nasal polyp recurrence in AERD patients, and 2) characterize the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $468,000.00 to the University of Colorado-Denver to conduct research on the regulation and function of tissue-resident eosinophils, which play a key role in allergic and inflammatory diseases. The research aims to elucidate the factors enabling eosinophil differentiation, how differentiated eosinophils interact with...
This Project Grant award, totaling $831,755, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine. The funding supports research to investigate the role of lung-resident macrophage subsets, particularly nerve- and airway-associated macrophages (NAMs), in regulating type 2 immune responses and trained immunity following infections that trigger a robust...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $143,450 to support research on developing therapies for treating viral-induced acute lung injury. The primary focus is on evaluating the therapeutic efficacy of combinations of PPARG agonist and RXR ligand compounds in cotton rat models of influenza and respiratory syncytial virus (RSV) infection. The research...
This federal Project Grant award, totaling $472,210.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to investigate the spatiotemporal relationship between CD4+ T resident memory cells and neutrophil recruitment in the lungs during pneumonia, while developing a transcriptional atlas of immune processes in the experienced lung. Key objectives include...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA Program 93.837 Cardiovascular Diseases Research) provides $480,990 to the University of Illinois to conduct research on the role of aerocytes, a recently identified capillary endothelial cell population, in regulating alveolar regeneration following lung injury. The research aims to establish the central role of aerocytes and the signaling molecule R-spondin3 in guiding regenerative alveolar remodeling, with the...